The tumor microenvironment: A potential arbitrator of the tumor suppressive and promoting actions of TGFβ

Differentiation

Volumn 70, Issue 9-10, 2002, Pages 574-582

  Dumont, Nancy ^b   Arteaga, Carlos L ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Extracellular matrix; Integrin; Latency associated peptide; Matrix metalloproteinase; Plasmin; Thrombospondin; Transforming growth factor

Indexed keywords

ANTIESTROGEN; CALPAIN; CATHEPSIN G; COLECALCIFEROL DERIVATIVE; GELATINASE A; GELATINASE B; GLUCOCORTICOID; GLYCOSIDASE; GROWTH FACTOR; INTEGRIN; MATRIX METALLOPROTEINASE; PLASMIN; RETINOID; THROMBOSPONDIN; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; CANCER INVASION; CARCINOGENESIS; CELL INTERACTION; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH;

ANIMALIA;

EID: 12244293337     PISSN: 03014681     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-0436.2002.700910.x     Document Type: Review

References (95)

1. Abe, M., Oda, N. and Sato, Y. (1998) Cell-associated activation of latent transforming growth factor-β by calpain. J Cell Physiol 174:186-193.
2. Albo, D., Berger, D.H., Wang, T.N., Hu, X., Rothman, V. and Tuszynski, G.P. (1997) Thrombospondin-1 and transforming growth factor-beta 1 promote breast tumor cell invasion through up-regulation of the plasminogen/plasmin system. Surgery 122:493-499discussion 499-500.
3. Andreasen, P.A., Egelund, R. and Petersen, H.H. (2000) The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 57:25-40.
4. Annes, J.P., Rifkin, D.B. and Munger, J.S. (2002) The integrin alphaVbeta6 binds and activates latent TGFβ3. FEBS Lett 511:65-68.
5. Antonelli-Orlidge, A., Saunders, K.B., Smith, S.R. and D'Amore, P.A. (1989) An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci U S A 86:4544-4548.
6. Arnoletti, J.P., Albo, D., Granick, M.S., Solomon, M.P., Castiglioni, A., Rothman, V.L. and Tuszynski, G.P. (1995) Thrombospondin and transforming growth factor-β1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells. Cancer 76:998-1005.
7. Barcellos-Hoff, M.H. (1993) Radiation-induced transforming growth factor β and subsequent extracellular matrix reorganization in murine mammary gland. Cancer Res 53:3880-3886.
8. Barcellos-Hoff, M.H. and Dix, T.A. (1996) Redox-mediated activation of latent transforming growth factor-β1. Mol Endocrinol 10:1077-1083.
9. Berking, C., Takemoto, R., Schaider, H., Showe, L., Satyamoorthy, K., Robbins, P. and Herlyn, M. (2001) Transforming growth factor-β1 increases survival of human melanoma through stroma remodeling. Cancer Res 61:8306-8316.
10. Bhowmick, N.A., Zent, R., Ghiassi, M., McDonnell, M. and Moses, H.L. (2001) Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity. J Biol Chem 276:46707-46713.
11. Boulanger, J., Reyes-Moreno, C. and Koutsilieris, M. (1995) Mediation of glucocorticoid receptor function by the activation of latent transforming growth factor β1 in MG-63 human osteosarcoma cells. Int J Cancer 61:692-697.
12. Breuss, J.M., Gallo, J., DeLisser, H.M., Klimanskaya, I.V., Folkesson, H.G., Pittet, J.F., Nishimura, S.L., Aldape, K., Landers, D.V., Carpenter, W., et, al. (1995) Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci 108:2241-2251.
13. Brown, P.D., Wakefield, L.M., Levinson, A.D. and Sporn, M.B. (1990) Physiochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3. Growth Factors 3.35-43.
14. Bugge, T.H., Lund, L.R., Kombrinck, K.K., Nielsen, B.S., Holmback, K., Drew, A.F., Flick, M.J., Witte, D.P., Dano, K. and Degen, J.L. (1998) Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice. Oncogene 16:3097-3104.
15. Cambier, S., Mu, D.Z., O'Connell, D., Boylen, K., Travis, W., Liu, W.H., Broaddus, V.C. and Nishimura, S.L. (2000) A role for the integrin alphavbeta8 in the negative regulation of epithelial cell growth. Cancer Res 60:7084-7093.
16. Crawford, S.E., Stellmach, V., Murphy-Ullrich, J.E., Ribeiro, S.M., Lawler, J., Hynes, R.O., Boivin, G.P. and Bouck, N. (1998) Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell 93:1159-1170.
17. Dennis, P.A. and Rifkin, D.B. (1991) Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci U S A 88:580-584.
18. Derynck, R., Akhurst, R.J. and Balmain, A. (2001) TGF-β signaling in tumor suppression and cancer progression. Nat Genet 29:117-129.
19. Dumont, N. (1999) Genetic and epigenetic contributions to colorectal cancer. APMIS 107:711-722.
20. Dumont, N. and Arteaga, C.L. (2000) Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-beta. Breast Cancer Res 2:125-132.
21. Faassen, A.E., Mooradian, D.L., Tranquillo, R.T., Dickinson, R.B., Letourneau, P.C., Oegema, T.R. and McCarthy, J.B. (1993) Cell surface CD44-related chondroitin sulfate proteoglycan is required for transforming growth factor-β-stimulated mouse melanoma cell motility and invasive behavior on type I collagen. J Cell Sci 105:501-511.
22. Farina, A.R., Coppa, A., Tiberio, A., Tacconelli, A., Turco, A., Colletta, G., Gulino, A. and Mackay, A.R. (1998) Transforming growth factor-β1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulating urokinase activity. Int J Cancer 75:721-730.
23. Festuccia, C., Angelucci, A., Gravina, G.L., Villanova, I.I., Teti, A., Albini, A. and Bologna, M. (2000) Osteoblast-derived TGFbeta-1 modulates matrix degrading protease expression and activity in prostate cancer cells. Int J Cancer 85:407-415.
24. Friess, H., Lu, Z., Riesle, E., Uhl, W., Brundler, A.M., Horvath, L., Gold, L.I., Korc, M. and Buchler, M.W. (1998) Enhanced expression of TGF-βs and their receptors in human acute pancreatitis. Ann Surg 227:95-104.
25. Glick, A., Popescu, N., Alexander, V., Ueno, H., Bottinger, E. and Yuspa, S.H. (1999) Defects in transforming growth factor-beta signaling cooperate with a Ras oncogene to cause rapid aneuploidy and malignant transformation of mouse keratinocytes. Proc Natl Acad Sci U S A 96:14949-14954.
26. Glick, A.B., Flanders, K.C., Danielpour, D., Yuspa, S.H. and Sporn, M.B. (1989) Retinoic acid induces transforming growth factor-β2 in cultured keratinocytes and mouse epidermis. Cell Regul 1:87-97.
27. Glick, A.B., Weinberg, W.C., Wu, I.H., Quan, W. and Yuspa, S.H. (1996) Transforming growth factor beta 1 suppresses genomic instability independent of a G1 arrest p53, Rb. Cancer Res 56:3645-3650.
28. Godar, S., Horejsi, V., Weidle, U.H., Binder, B.R., Hansmann, C. and Stockinger, H. (1999) M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-betal. Eur J Immunol 29:1004-1013.
29. Gorska, A.E., Joseph, H., Derynck, R., Moses, H.L. and Serra, R. (1998) Dominant-negative interference of the transforming growth factor β type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice. Cell Growth Differ 9:229-238.
30. Goumans, M.J., Valdimarsdottir, G., Itoh, S., Rosendahl, A., Sideras, P. and ten Dijke, P. (2002) Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J 21:1743-1753.
31. Grady, W.M. and Markowitz, S.D. (2002) Genetic and Epigenetic Alterations in Colon Cancer. Annu Rev Genomics Hum Genet 3:101-128.
32. Hahn, S.A., Schutte, M., Hoque, A.T., Moskaluk, C.A., da Costa, L.T., Rozenblum, E., Weinstein, C.L., Fischer, A., Yeo, C.J., Hruban, R.H. and Kern, S.E. (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350-353.
33. Higashi, T., Sasagawa, T., Inoue, M., Oka, R., Shuangying, L. and Saijoh, K. (2001) Overexpression of latent transforming growth factor-beta 1 (TGF-beta 1) binding protein 1 (LTBP-1) in association with TGF-beta 1 in ovarian carcinoma. Jpn J Cancer Res 92:506-515.
34. Hojo, M., Morimoto, T., Maluccio, M., Asano, T., Morimoto, K., Lagman, M., Shimbo, T. and Suthanthiran, M. (1999) Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 397:530-534.
35. Hynes, R.O. (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11-25.
36. Ito, N., Kawata, S., Tamura, S., Shirai, Y., Kiso, S., Tsushima, H. and Matsuzawa, Y. (1995) Positive correlation of plasma transforming growth factor-β1 levels with tumor vascularity in hepatocellular carcinoma. Cancer Lett 89:45-48.
37. Janji, B., Melchior, C., Gouon, V., Vallar, L. and Kieffer, N. (1999) Autocrine TGF-β-regulated expression of adhesion receptors and integrin-linked kinase in HT-144 melanoma cells correlates with their metastatic phenotype. Int J Cancer 83:255-262.
38. Jullien, P., Berg, T.M. and Lawrence, D.A. (1989) Acidic cellular environments: activation of latent TGF-β and sensitization of cellular responses to TGF-β and EGF. Int J Cancer 43:886-891.
39. Kim, K.Y., Jeong, S.Y.; Won, J., Ryu, P.D. and Nam, M.J. (2001) Induction of angiogenesis by expression of soluble type II transforming growth factor-beta receptor in mouse hepatoma. J Biol Chem 276:38781-38786.
40. Kim, L.T. and Yamada, K.M. (1997) The regulation of expression of integrin receptors. Proc Soc Exp Biol Med 214:123-131.
41. Kim, S.J., Im, Y.H., Markowitz, S.D. and Bang, Y.J. (2000) Molecular mechanisms of inactivation of TGF-β receptors during carcinogenesis. Cytokine Growth Factor Rev 11:159-168.
42. Knabbe, C., Lippman, M.E., Wakefield, L.M., Flanders, K.C., Kasid, A., Derynck, R. and Dickson, R.B. (1987) Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48:417-428.
43. Koli, K. and Keski-Oja, J. (1993) Vitamin D3 and calcipotriol enhance the secretion of transforming growth factor-β1 and -β2 in cultured murine keratinocytes. Growth Factors 8:153-163.
44. Koli, K., Saharinen, J., Hyytiainen, M., Penttinen, C. and Keski-Oja, J. (2001) Latency, activation, and binding proteins of TGF-β. Microsc Res Tech 52:354-362.
45. Lawler, J. (2002) Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Mol Med 6:1-12.
46. Lin, S.W., Lee, M.T., Ke, F.C., Lee, P.P., Huang, C.J., Ip, M.M., Chen, L. and Hwang, J.J. (2000) TGFbetal stimulates the secretion of matrix metalloproteinase 2 (MMP2) and the invasive behavior in human ovarian cancer cells, which is suppressed by MMP inhibitor BB3103. Clin Exp Metastasis 18:493-499.
47. Lyons, R.M., Gentry, L.E., Purchio, A.F. and Moses, H.L. (1990) Mechanism of activation of latent recombinant transforming growth factor β1 by plasmin. J Cell Biol 110:1361-1367.
48. Lyons, R.M., Keski-Oja, J. and Moses, H.L. (1988) Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium. J Cell Biol 106:1659-1665.
49. Mandriota, S.J., Menoud, P.A. and Pepper, M.S. (1996) Transforming growth factor beta 1 down-regulates vascular endothelial growth factor receptor 2/flk-1 expression in vascular endothelial cells. J Biol Chem 271:11500-11505.
50. Markowitz, S.D. and Roberts, A.B. (1996) Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev 7:93-102.
51. Massagué, J. (1990) The transforming growth factor-β family. Annu Rev Cell Biol 6:597-641.
52. McCawley, L.J. and Matrisian, L.M. (2000) Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today 6:149-156.
53. Miao, W.M., Seng, W.L., Duquette, M., Lawler, P., Laus, C. and Lawler, J. (2001) Thrombospondin-1 type 1 repeat recombinant proteins inhibit tumor growth through transforming growth factor-β-dependent and -independent mechanisms. Cancer Res 61:7830-7839.
54. Minami, T., Rosenberg, R.D. and Aird, W.C. (2001) Transforming growth factor-beta 1-mediated inhibition of the flk-1/KDR gene is mediated by a 5′-untranslated region palindromic GATA site. J Biol Chem 276:5395-5402.
55. Miyazono, K. and Heldin, C.H. (1989) Role for carbohydrate structures in TGF-β1 latency. Nature 338:158-160.
56. Miyazono, K., Ichijo, H. and Heldin, C.H. (1993) Transforming growth factor-β: latent forms, binding proteins and receptors. Growth Factors 8:11-22.
57. Moretti, S., Pinzi, C., Berti, E., Spallanzani, A., Chiarugi, A., Boddi, V., Reali, U.M. and Giannotti, B. (1997) In situ expression of transforming growth factor β is associated with melanoma progression and correlates with Ki67, HLA-DR and beta 3 integrin expression. Melanoma Res 7:313-321.
58. Moses, H.L., Yang, E.Y. and Pietenpol, J.A. (1990) TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63:245-247.
59. Mu, D., Cambier, S., Fjellbirkeland, L., Baron, J.L., Munger, J.S., Kawakatsu, H., Sheppard, D., Broaddus, V.C. and Nishimura, S.L. (2002) The integrin alphavbeta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-β1. J Cell Biol 157:493-507.
60. Munger, J.S., Harpel, J.G., Giancotti, F.G. and Rifkin, D.B. (1998) Interactions between growth factors and integrins: latent forms of transforming growth factor-β are ligands for the integrin alphavbeta1. Mol Biol Cell 9:2627-2638.
61. Munger, J.S., Huang, X., Kawakatsu, H., Griffiths, M.J., Dalton, S.L., Wu, J., Pittet, J.F., Kaminski, N., Garat, C., Matthay, M.A., Rifkin, D.B. and Sheppard, D. (1999) The integrin alphav beta 6 binds and activates latent TGFβ1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96:319-328.
62. Muraoka, R.S., Dumont, N., Ritter, C.A., Dugger, T.C., Brantley, D.M., Chen, J., Easterly, E., Roebuck, L.R., Ryan, S., Gotwals, P.J., Koteliansky, V. and Arteaga, C.L. (2002) Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases. J Clin Invest 109:1551-1559.
63. Nishimura, S.L., Boylen, K.P., Einheber, S., Milner, T.A., Ramos, D.M. and Pytela, R. (1998) Synaptic and glial localization of the integrin alphavbeta8 in mouse and rat brain. Brain Res 791:271-282.
64. Nunes, I., Shapiro, R.L. and Rifkin, D.B. (1995) Characterization of latent TGF-beta activation by murine peritoneal macrophages. J Immunol 155:1450-1459.
65. Oft, M., Heider, K.H. and Beug, H. (1998) TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 8:1243-1252.
66. Okamoto, M., Ono, M., Uchiumi, T., Ueno, H., Kohno, K., Sugimachi, K. and Kuwano, M. (2002) Up-regulation of thrombospondin-1 gene by epidermal growth factor and transforming growth factor beta in human cancer cells - transcriptional activation and messenger RNA stabilization. Biochim Biophys Acta 1574:24-34.
67. Overall, C.M., Wrana, J.L. and Sodek, J. (1991) Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-β1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J Biol Chem 266:14064-14071.
68. Pepper, M.S. (1997) Transforming growth factor-β: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 8:21-43.
69. Pierce, D.F. Jr, Gorska, A.E., Chytil, A., Meise, K.S., Page, D.L., Coffey, R.J. Jr and Moses, H.L. (1995) Mammary tumor suppression by transforming growth factor beta 1 transgene expression. Proc Natl Acad Sci U S A 92:4254-4258.
70. Pierce, D.F. Jr, Johnson, M.D., Matsui, Y., Robinson, S.D., Gold, L.I., Purchio, A.F., Daniel, C.W., Hogan, B.L. and Moses, H.L. (1993) Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1. Genes Dev 7:2308-2317.
71. Portella, G., Cumming, S.A., Liddell, J., Cui, W., Ireland, H., Akhurst, R.J. and Balmain, A. (1998) Transforming growth factor β is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion. Cell Growth Differ 9:393-404.
72. Rodriguez-Manzaneque, J.C., Lane, T.F., Ortega, M.A., Hynes, R.O., Lawler, J. and Iruela-Arispe, M.L. (2001) Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. Proc Natl Acad Sci U S A 98:12485-12490.
73. Rowland-Goldsmith, M.A., Maruyama, H., Kusama, T., Ralli, S. and Korc, M. (2001) Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation. Clin Cancer Res 7:2931-2940.
74. Samuel, S.K., Hurta, R.A., Kondaiah, P., Khalil, N., Turley, E.A., Wright, J.A. and Greenberg, A.H. (1992) Autocrine induction of tumor protease production and invasion by a metallothionein-regulated TGF-β1 (Ser223, 225). EMBO J 11:1599-1605.
75. Sato, Y. and Rifkin, D.B. (1989) Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-β1-like molecule by plasmin during co-culture. J Cell Biol 109:309-315.
76. Schultz-Cherry, S. and Murphy-Ullrich, J.E. (1993) Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism. J Cell Biol 122:923-932.
77. Schultz-Cherry, S., Ribeiro, S., Gentry, L. and Murphy-Ullrich, J.E. (1994) Thrombospondin binds and activates the small and large forms of latent transforming growth factor-β in a chemically defined system. J Biol Chem 269:26775-26782.
78. Schuster, N. and Krieglstein, K. (2002) Mechanisms of TGF-β-mediated apoptosis. Cell Tissue Res 307:1-14.
79. Schutte, M., Hruban, R.H., Hedrick, L., Cho, K.R., Nadasdy, G.M., Weinstein, C.L., Bova, G.S., Isaacs, W.B., Cairns, P., Nawroz, H., Sidransky, D., Casero, R.A. Jr, Meltzer, P.S., Hahn, S.A. and Kern, S.E. (1996) DPC4 gene in various tumor types. Cancer Res 56:2527-2530.
80. Schwarte-Waldhoff, I., Klein, S., Blass-Kampmann, S., Hintelmann, A., Eilert, C., Dreschers, S., Kalthoff, H., Hahn, S.A. and Schmiegel, W. (1999) DPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expression. Oncogene 18:3152-3158.
81. Sehgal, I., Baley, P.A. and Thompson, T.C. (1996) Transforming growth factor β1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro. Cancer Res 56:3359-3365.
82. Shin, I., Bakin, A.V., Rodeck, U., Brunet, A. and Arteaga, C.L. (2001) Transforming growth factor β enhances epithelial cell survival via Akt-dependent regulation of FKHRL1. Mol Biol Cell 12:3328-3339.
83. Taipale, J., Miyazono, K., Heldin, C.H. and Keski-Oja, J. (1994) Latent transforming growth factor-β1 associates to fibroblast extracellular matrix via latent TGF-β binding protein. J Cell Biol 124:171-181.
84. Thiagalingam, S., Lengauer, C., Leach, F.S., Schutte, M., Hahn, S.A., Overhauser, J., Willson, J.K., Markowitz, S., Hamilton, S.R., Kern, S.E., Kinzler, K.W. and Vogelstein, B. (1996) Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 13:343-346.
85. Thomas, G.J., Lewis, M.P., Hart, I.R., Marshall, J.F. and Speight, P.M. (2001) AlphaVbeta6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9. Int J Cancer 92:641-650.
86. Ueki, N., Nakazato, M., Ohkawa, T., Ikeda, T, Amuro, Y., Hada, T and Higashino, K (1992) Excessive production of transforming growth-factor β1 can play an important role in the development of tumorigenesis by its action for angiogenesis: validity of neutralizing antibodies to block tumor growth. Biochim Biophys Acta 1137:189-196.
87. Wakefield, L.M. and Roberts, A.B. (2002) TGF-β signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 12:22-29.
88. Wang, D., Sun, L., Zborowska, E., Willson, J.K., Gong, J., Verraraghavan, J. and Brattain, M.G. (1999) Control of type II transforming growth factor-beta receptor expression by integrin ligation. J Biol Chem 274:12840-12847.
89. Wang, S., Souza, R.F., Kong, D., Yin, J., Smolinski, K.N., Zou, T.T., Frank, T., Young, J., Flanders, K.C., Sugimura, H., Abraham, J.M. and Meltzer, S.J. (1997) Deficient transforming growth factor-betal activation and excessive insulin-like growth factor II (IGFII) expression in IGFII receptor-mutant tumors. Cancer Res 57:2543-2546.
90. Weeks, B.H., He, W., Olson, K.L. and Wang, X.J. (2001) Inducible expression of transforming growth factor betal in papillomas causes rapid metastasis. Cancer Res 61:7435-7443.
91. Wikstrom, P., Stattin, P., Franck-Lissbrant, I., Damber, J.E. and Bergh, A. (1998) Transforming growth factor β1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer. Prostate 37:19-29.
92. Yin, J.J., Selander, K., Chirgwin, J.M., Dallas, M., Grubbs, B.G., Wieser, R., Massagué, J., Mundy, G.R. and Guise, T.A. (1999) TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest 103:197-206.
93. Yu, Q. and Stamenkovic, I. (1999) Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 13:35-48.
94. Yu, Q. and Stamenkovic, I. (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev 14:163-176.
95. Zavadil, J., Bitzer, M., Liang, D., Yang, Y.C., Massimi, A., Kneitz, S., Piek, E. and Bottinger, E.P. (2001) Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc Natl Acad Sci U S A 98:6686-6691.